Welsh stem cell company Cell Therapy Ltd. has granted Japanese drugmaker Daiichi Sankyo a license for Heartcelâ„¢, its promising cardiac regeneration medicine. Under the conditions of the deal, Daiichi Sankyo
Vericel
About Us
Evolution Bioscience is a global consultancy firm, specialising in market intelligence, strategy formulation, technology transfer and commercialisation services, covering the full range of Biotechnology sectors.Recent Posts
2016 © Evolution Bioscience / Darwin Hutton Partners